DOI QR코드

DOI QR Code

Validation of Serum Aminotransferases Levels to Define Severe Dengue Fever in Children

  • Srivastava, Geetika (Department of Pediatrics, Era's Lucknow Medical College) ;
  • Chhavi, Nanda (Department of Pediatrics, Era's Lucknow Medical College) ;
  • Goel, Amit (Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences)
  • Received : 2018.01.29
  • Accepted : 2018.04.11
  • Published : 2018.10.15

Abstract

Purpose: We aimed to study the pattern of liver-injury in children with dengue fever (DF) and validate serum aminotransferase ${\geq}1,000IU/L$ as a marker of severe DF. Methods: Children admitted with DF were included. DF was defined by presence of clinical criteria and positive serological or antigen tests in absence of other etiology. DF severity was graded as dengue without or with warning signs and severe dengue. Liver-injury was defined as alanine aminotransferase (ALT) more than twice the upper limit of normal (boys, 30 IU/L; girls, 21 IU/L). Results: Of 372 children with DF, 144 (38.7%) had liver-injury. Risk of liver-injury and aminotransferase levels increased with DF severity (p<0.001). Recommended ALT and aspartate aminotransferase (AST) cut-off at ${\geq}1,000IU/L$ had sensitivity 4.8% (5/105), specificity 99.3% (265/267) for detection of severe DF. In children with ALT and AST <1,000 IU/L (n=365), the area under receiver operating curves for prediction for severe DF, were 0.651 (95% confidence interval [CI], 0.588-0.714; p<0.001) for ALT and 0.647 (95% CI, 0.582-0.712; p<0.001) for AST. Serum ALT at 376 IU/L and AST at 635 IU/L had sensitivity and specificity comparable to ${\geq}1,000IU/L$ for defining severe DF. Conclusion: Liver-injury is common in DF. The ALT and AST levels increase with DF severity. ALT and AST levels of ${\geq}1,000IU/L$ could be lowered to 376 IU/L and 635 IU/L respectively for defining severe DF.

Keywords

References

  1. World Health Organization. Dengue: guidelines for diagnosis treatment prevention and control. Geneva: WHO, 2009. 147 p.
  2. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Geneva: WHO, 1997. 84 p.
  3. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, et al. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health 2011;16:936-48. https://doi.org/10.1111/j.1365-3156.2011.02793.x
  4. Barniol J, Gaczkowski R, Barbato EV, da Cunha RV, Salgado D, Martinez E, et al. Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infect Dis 2011;11:106. https://doi.org/10.1186/1471-2334-11-106
  5. Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg 2006;100:608-14. https://doi.org/10.1016/j.trstmh.2005.10.007
  6. Ling LM, Wilder-Smith A, Leo YS. Fulminant hepatitis in dengue haemorrhagic fever. J Clin Virol 2007;38: 265-8. https://doi.org/10.1016/j.jcv.2006.12.011
  7. Souza LJ, Alves JG, Nogueira RM, Gicovate Neto C, Bastos DA, Siqueira EW, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis 2004;8:156-63.
  8. Kye Mon K, Nontprasert A, Kittitrakul C, Tangkijvanich P, Leowattana W, Poovorawan K. Incidence and clinical outcome of acute liver failure caused by dengue in a hospital for tropical diseases, Thailand. Am J Trop Med Hyg 2016;95:1338-44. https://doi.org/10.4269/ajtmh.16-0374
  9. Ahmad S, Dhar M, Srivastava S, Bhat NK, Shirazi N, Biswas D, et al. Dengue hepatitis sans dysfunction: experience of a single tertiary referral centre in the north Indian state of Uttarakhand. Trop Doct 2013;43:62-5. https://doi.org/10.1177/0049475513483281
  10. Itha S, Kashyap R, Krishnani N, Saraswat VA, Choudhuri G, Aggarwal R. Profile of liver involvement in dengue virus infection. Natl Med J India 2005; 18:127-30.
  11. Saha AK, Maitra S, Hazra SCh. Spectrum of hepatic dysfunction in 2012 dengue epidemic in Kolkata, West Bengal. Indian J Gastroenterol 2013;32:400-3. https://doi.org/10.1007/s12664-013-0382-6
  12. Poustchi H, George J, Esmaili S, Esna-Ashari F, Ardalan G, Sepanlou SG, et al. Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence. PLoS One 2011;6:e21178. https://doi.org/10.1371/journal.pone.0021178
  13. Schiff ER, Sorrell MF, Maddrey WC, Schiff L. Schiff's diseases of the liver. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2007.
  14. Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. N Am J Med Sci 2013;5:480-5. https://doi.org/10.4103/1947-2714.117313
  15. Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue fever in children. Iran J Pediatr 2012;22:231-6.
  16. Martinez Vega R, Phumratanaprapin W, Phonrat B, Dhitavat J, Sutherat M, Choovichian V. Differences in liver impairment between adults and children with dengue infection. Am J Trop Med Hyg 2016;94:1073-9. https://doi.org/10.4269/ajtmh.15-0507
  17. Chongsrisawat V, Hutagalung Y, Poovorawan Y. Liver function test results and outcomes in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health 2009;40:47-53.
  18. Lee LK, Gan VC, Lee VJ, Tan AS, Leo YS, Lye DC. Clinical relevance and discriminatory value of elevated liver aminotransferase levels for dengue severity. PLoS Negl Trop Dis 2012;6:e1676. https://doi.org/10.1371/journal.pntd.0001676
  19. Chhavi N, Zutshi K, Singh NK, Awasthi A, Goel A. Serum liver enzyme pattern in birth asphyxia associated liver injury. Pediatr Gastroenterol Hepatol Nutr 2014;17:162-9. https://doi.org/10.5223/pghn.2014.17.3.162

Cited by

  1. Assessment of Severity of Dengue Fever by Deranged Alanine Aminotransferase Levels vol.12, pp.9, 2020, https://doi.org/10.7759/cureus.10539